217 related articles for article (PubMed ID: 14613859)
1. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
3. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
4. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Wirth KJ; Knobloch K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
[TBL] [Abstract][Full Text] [Related]
6. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
de Haan S; Greiser M; Harks E; Blaauw Y; van Hunnik A; Verheule S; Allessie M; Schotten U
Circulation; 2006 Sep; 114(12):1234-42. PubMed ID: 16940189
[TBL] [Abstract][Full Text] [Related]
7. Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.
Schneider HJ; Husser O; Rihm M; Fredersdorf S; Birner C; Dhein S; Muders F; Jeron A; Goegelein H; Riegger GA; Luchner A
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):225-32. PubMed ID: 18972103
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
[TBL] [Abstract][Full Text] [Related]
9. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
[TBL] [Abstract][Full Text] [Related]
10. Potential ionic mechanism for repolarization differences between canine right and left atrium.
Li D; Zhang L; Kneller J; Nattel S
Circ Res; 2001 Jun; 88(11):1168-75. PubMed ID: 11397783
[TBL] [Abstract][Full Text] [Related]
11. Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.
Burashnikov A; Barajas-Martinez H; Hu D; Nof E; Blazek J; Antzelevitch C
J Cardiovasc Pharmacol; 2012 Jun; 59(6):539-46. PubMed ID: 22370957
[TBL] [Abstract][Full Text] [Related]
12. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
13. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
[TBL] [Abstract][Full Text] [Related]
14. Effects of potassium channel blockers on changes in refractoriness of atrial cardiomyocytes induced by stretch.
Qi J; Xiao J; Zhang Y; Li J; Liu Y; Li P; Liang L; Jiang B; Wen W; Zhao C; Liang D; Liu Y; Chen YH
Exp Biol Med (Maywood); 2009 Jul; 234(7):779-84. PubMed ID: 19429854
[TBL] [Abstract][Full Text] [Related]
15. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
Gögelein H; Brendel J; Steinmeyer K; Strübing C; Picard N; Rampe D; Kopp K; Busch AE; Bleich M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):183-92. PubMed ID: 15340774
[TBL] [Abstract][Full Text] [Related]
16. Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange.
Schotten U; de Haan S; Verheule S; Harks EG; Frechen D; Bodewig E; Greiser M; Ram R; Maessen J; Kelm M; Allessie M; Van Wagoner DR
Cardiovasc Res; 2007 Jan; 73(1):37-47. PubMed ID: 17157284
[TBL] [Abstract][Full Text] [Related]
17. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
[TBL] [Abstract][Full Text] [Related]
18. In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions.
Nakashima H; Gerlach U; Schmidt D; Nattel S
Cardiovasc Res; 2004 Mar; 61(4):705-14. PubMed ID: 14985067
[TBL] [Abstract][Full Text] [Related]
19. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
Kambayashi R; Hagiwara-Nagasawa M; Ichikawa T; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Takahara A; Sugiyama A
Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771
[TBL] [Abstract][Full Text] [Related]
20. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
